0 CHECKOUT

United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3526570
  • January 2016
  • Region: United Arab Emirates
  • 97 pages
  • Business Monitor International
1 of 4

The UAE will continue to be an attractive emerging market for pharmaceutical companies as a result of continued investment into the country's healthcare sector. The rising prevalence of chronic diseases, such as diabetes, is prompting both the public and private sector to improve the population's access to healthcare services - this will act as the main driver of pharmaceutical expenditure in the UAE.

However, during this period of oil price-driven austerity, the government is more likely to cut back spending on higher-value innovative drugs, posing a risk to multinational drugmakers.

Headline Expenditure Projections
- Pharmaceuticals: AED9.46bn (USD2.58bn) in 2014 to AED10.32bn (USD2.81bn) in 2015; +9.1% in local currency terms and +9.2% US dollar terms. Forecast unchanged from last quarter.

- Healthcare: AED49.88bn (USD13.58bn) in 2014 to AED52.64bn (USD14.34bn) in 2015; +5.5% in local currency terms and 5.6% in US dollar terms. Forecast revised upwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (United Arab Emirates 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019)

Prescription Drug Market Forecast
Table: UAE Healthcare Demand Split By Therapeutic Area
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2013-2019)

Industry Risk/Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

United Arab Emirates Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Regime

Regulatory Developments

Pharmacovigilance

Pharmaceutical Advertising

Intellectual Property Issues

Pricing Regime

Pricing And Reimbursement Developments

Regional Harmonisation

Market Overview

Epidemiology
Table: UAE Healthcare Demand Split By Therapeutic Area

Healthcare Sector

Healthcare Sector Developments
Table: Healthcare Resources (United Arab Emirates 2009-2014)
Table: Healthcare Personnel (United Arab Emirates 2009-2014)
Table: Healthcare Activity (United Arab Emirates 2009-2014)

Health Insurance

Medical Tourism

Research & Development

Clinical Trials

Competitive Landscape

Pharmaceutical Sector
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area

Domestic Industry

Foreign Industry

Recent Company Developments
Table: Table: Multinational Market Activity

Pharmaceutical Distribution And Retail

Recent Developments

Company Profile

Gulf Pharmaceutical Industries (Julphar)

Neopharma

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (United Arab Emirates 1990-2025)
Table: Key Population Ratios (United Arab Emirates 1990-2025)
Table: Urban/Rural Population & Life Expectancy (United Arab Emirates 1990-2025)
Table: Population By Age Group (United Arab Emirates 1990-2025)
Table: Population By Age Group % (United Arab Emirates 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Gulf Pharmaceutical Industries (Julphar)
Neopharma

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.